These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9253545)

  • 41. Impact of dietary intervention, sex, and apolipoprotein E phenotype on tracking of serum lipids and apolipoproteins in 1- to 5-year-old children: the Special Turku Coronary Risk Factor Intervention Project (STRIP).
    Rask-Nissilä L; Jokinen E; Viikari J; Tammi A; Rönnemaa T; Marniemi J; Salo P; Routi T; Helenius H; Välimäki I; Simell O
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):492-8. PubMed ID: 11884296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk.
    Pallebage-Gamarallage MM; Takechi R; Lam V; Galloway S; Dhaliwal S; Mamo JC
    Atheroscler Suppl; 2010 Jun; 11(1):49-54. PubMed ID: 20430703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lipid metabolism in the central nervous system and neurodegenerative diseases].
    Hayashi H
    Nihon Yakurigaku Zasshi; 2011 Jun; 137(6):227-31. PubMed ID: 21666340
    [No Abstract]   [Full Text] [Related]  

  • 44. Blood coagulability and lipid metabolism in patients with coronary insufficiency.
    Panchenko VM; Bazaz'yan GG
    Fed Proc Transl Suppl; 1966; 25(5):800-2. PubMed ID: 5223562
    [No Abstract]   [Full Text] [Related]  

  • 45. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
    Kesäniemi YA; Ehnholm C; Miettinen TA
    J Clin Invest; 1987 Aug; 80(2):578-81. PubMed ID: 3611358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
    Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
    Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease.
    Klos KL; Kardia SL; Ferrell RE; Turner ST; Boerwinkle E; Sing CF
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):971-8. PubMed ID: 11397706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease.
    Souza DR; Nakachima L; Biagioni RB; Nakazone MA; Pinhel MA; Trindade DM; Mafra VT; Tácito LH; Martin JF; Pinheiro Júnior S; Brandão AC
    Braz J Med Biol Res; 2007 Feb; 40(2):189-97. PubMed ID: 17273655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antihypertensive therapy of the patients with hyperlipidemia].
    Umeda T; Sato T; Hamasaki S; Fujimoto Y
    Nihon Rinsho; 1992 May; 50 Suppl():211-7. PubMed ID: 1512959
    [No Abstract]   [Full Text] [Related]  

  • 50. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
    Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose.
    Erkkilä AT; Sarkkinen ES; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Am J Clin Nutr; 2001 Apr; 73(4):746-52. PubMed ID: 11273849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Apolipoprotein E in lipid transport].
    Gómez Gerique JA
    Rev Clin Esp; 1992 Feb; 190(3):137-48. PubMed ID: 1313988
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH; Brenta G
    Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Introduction.
    Levey RI; Leren P
    Am J Med; 1986 Feb; 80(2A):1-2. PubMed ID: 3946455
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of apolipoprotein E genotypes on cerebral blood flow and metabolism following traumatic brain injury.
    Kerr ME; Kraus M; Marion D; Kamboh I
    Adv Exp Med Biol; 1999; 471():117-24. PubMed ID: 10659138
    [No Abstract]   [Full Text] [Related]  

  • 56. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach.
    de Knijff P; Havekes LM
    Curr Opin Lipidol; 1996 Apr; 7(2):59-63. PubMed ID: 8743896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Apolipoprotein E and cholesterol].
    Miettinen TA
    Duodecim; 1990; 106(11):857-60. PubMed ID: 1670322
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparative study of lipid metabolism in ischemic heart disease and nephrotic syndrome].
    Dzhumaev DS; Shcherbakova IA; Titov VN
    Kardiologiia; 1976 Aug; 16(8):122-5. PubMed ID: 189118
    [No Abstract]   [Full Text] [Related]  

  • 59. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
    Laakso M; Kesäniemi A; Kervinen K; Jauhiainen M; Pyörälä K
    BMJ; 1991 Nov; 303(6811):1159-62. PubMed ID: 1747611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype.
    Nagai T; Tomizawa T; Saito T; Nakano T; Nakajima K; Mori M
    Intern Med; 1996 May; 35(5):388-91. PubMed ID: 8797053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.